AI takes on cancer radiotherapy: can a computer plan treatment in minutes?

NCT ID NCT05653063

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether an artificial intelligence program can automate two key steps in radiotherapy planning: outlining areas at risk of tumor spread or radiation damage, and designing the radiation beams. The AI tool is compared against the standard manual process done by oncologists and physicists. Over 1,000 patients with prostate, head and neck, or cervical cancer will participate to see if AI-generated plans meet clinical quality standards.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a web-based artificial intelligence auto-planning tool that automates contouring and beam design for radiotherapy
What this could lead to
If successful, AI could speed up radiotherapy planning from weeks to minutes, reduce human workload, and improve treatment accuracy for thousands of cancer patients.
What could go wrong
The AI plans must meet strict clinical standards; early-stage technology may fail in complex cases or require human oversight, limiting real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER CERVIX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Groote Schuur Hospital

    Cape Town, South Africa

  • King Hussein Cancer Center

    Amman, Jordan

  • Tata Medical Centre

    Kolkata, India

  • Tata Memorial Hospital

    Mumbai, India

  • Tygerberg Hospital

    Stellenbosch, South Africa

  • University of Malaya Medical Center

    Kuala Lumpur, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.